Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity

• Jasper David Feldkamp,
• Valentin Max Vetter,
• Christopher Maximilian Arends,
• Tonio Johannes Lukas Lang,
• Lars Bullinger,
• Frederik Damm,
• Ilja Demuth,
• Mareike Frick

Affiliations

Jasper David Feldkamp

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin

Valentin Max Vetter

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Endocrinology and Metabolic Disease (including Division of Lipid Metabolism), Biology of Aging working group, Berlin, Germany; Department of Psychology, Humboldt-Universität zu Berlin, Berlin

Christopher Maximilian Arends

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin

Tonio Johannes Lukas Lang

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin

Lars Bullinger

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg

Frederik Damm

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg

Ilja Demuth

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Endocrinology and Metabolic Disease (including Division of Lipid Metabolism), Biology of Aging working group, Berlin, Germany; Charité – Universitätsmedizin Berlin, BCRT - Berlin Institute of Health Center for Regenerative Therapies, Berlin

Mareike Frick

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg